CRISPR genome editing therapy lowers blood fats in early trial
A single infusion of an experimental CRISPR/Cas9 genome editing therapy reduced triglyceride levels by an average of 63 percent in people with severely elevated blood fats...
A research study in which new ways to prevent, detect, diagnose, or treat disease are tested on human participants.
A single infusion of an experimental CRISPR/Cas9 genome editing therapy reduced triglyceride levels by an average of 63 percent in people with severely elevated blood fats...
by BioNews
by Yan Lau
Switching back on a gene that is normally silenced early in development has improved features of severe alpha-thalassaemia in mice and restored globin production in cells from patients...
The US Food and Drug Administration has outlined a framework that could allow multiple related, patient-specific genome editing therapies to be covered by a single approval, for patients with different genetic variants of the same gene...
by BioNews
Prime editing – a type of genome editing – has been used to alter DNA directly inside a person's body for the first time...
From light-sensitive, single-celled algae to using lasers to trigger mouse whisker movements, the 2026 Nobel Prize in Physiology or Medicine recognises the discovery of light-gated ion channels and their applications in optogenetics to study brain function...
A gene therapy for Huntington's disease failed to show statistically significant slowing of disease progression after 48 months, according to newly released data...
by Tiago Macedo and 1 others
Researchers working in childhood cancer survivorship explain how patient-derived stem cells could one day expand fertility restoration options, for boys whose cancer treatment has damaged their developing testes…
A Phase 2/3 trial assessing a gene therapy for X-linked retinitis pigmentosa (XLRP) shows significant improvements in low-light vision...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.